These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27338131)

  • 1. Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer.
    Tupal A; Sabzichi M; Ramezani F; Kouhsoltani M; Hamishehkar H
    J Microencapsul; 2016 Jun; 33(4):372-80. PubMed ID: 27338131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Skin Cancer Therapy Using Doxorubicin-Loaded Cationic Lipid Nanoparticles and lontophoresis.
    Huber LA; Pereira TA; Ramos DN; Rezende LC; Emery FS; Sobral LM; Leopoldino AM; Lopez RF
    J Biomed Nanotechnol; 2015 Nov; 11(11):1975-88. PubMed ID: 26554156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of iontophoresis on topical delivery of doxorubicin-loaded solid lipid nanoparticles.
    Taveira SF; De Santana DC; Araújo LM; Marquele-Oliveira F; Nomizo A; Lopez RF
    J Biomed Nanotechnol; 2014 Jul; 10(7):1382-90. PubMed ID: 24804558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
    Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
    Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers.
    Wang C; Sun X; Wang K; Wang Y; Yang F; Wang H
    Drug Deliv; 2016 Oct; 23(8):2697-2702. PubMed ID: 26203692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.
    Zheng G; Zheng M; Yang B; Fu H; Li Y
    Biomed Pharmacother; 2019 Aug; 116():109006. PubMed ID: 31152925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
    Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
    J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation.
    Zhu B; Zhang H; Yu L
    Biomed Pharmacother; 2017 Feb; 86():547-554. PubMed ID: 28024291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy.
    Han Y; Zhang P; Chen Y; Sun J; Kong F
    Int J Mol Med; 2014 Jul; 34(1):191-6. PubMed ID: 24804644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Tocopherol succinate improves encapsulation and anticancer activity of doxorubicin loaded in solid lipid nanoparticles.
    Oliveira MS; Mussi SV; Gomes DA; Yoshida MI; Frezard F; Carregal VM; Ferreira LAM
    Colloids Surf B Biointerfaces; 2016 Apr; 140():246-253. PubMed ID: 26764108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: preparation, characterization, and in vitro cytotoxicity studies.
    Peira E; Chirio D; Battaglia L; Barge A; Chegaev K; Gigliotti CL; Ferrara B; Dianzani C; Gallarate M
    J Microencapsul; 2016 Jun; 33(4):381-90. PubMed ID: 27358106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
    Wang L; Wang W; Rui Z; Zhou D
    Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic ligand appended nanoconstructs: a prospective strategy for brain targeting.
    Agarwal A; Agrawal H; Tiwari S; Jain S; Agrawal GP
    Int J Pharm; 2011 Dec; 421(1):189-201. PubMed ID: 21986113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of cationic solid lipid nanoparticles with factorial design-based studies for topical administration of doxorubicin.
    Taveira SF; Araújo LM; de Santana DC; Nomizo A; de Freitas LA; Lopez RF
    J Biomed Nanotechnol; 2012 Apr; 8(2):219-28. PubMed ID: 22515073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Curcumin-Resveratrol Solid Nanoparticles Synergistically Inhibit Proliferation of Melanoma Cells.
    Palliyage GH; Hussein N; Mimlitz M; Weeder C; Alnasser MHA; Singh S; Ekpenyong A; Tiwari AK; Chauhan H
    Pharm Res; 2021 May; 38(5):851-871. PubMed ID: 33982225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells.
    Miao J; Du YZ; Yuan H; Zhang XG; Hu FQ
    Colloids Surf B Biointerfaces; 2013 Oct; 110():74-80. PubMed ID: 23711779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.